Literature DB >> 7773473

A comparative retrospective study of thoracoscopy versus thoracotomy for the treatment of spontaneous pneumothorax.

G Rådberg1, L Dernevik, J Svanvik, A Thune.   

Abstract

Thoracoscopic surgery has been claimed to reduce patient disability, recovery time, and hospital costs compared with open surgery. We analyzed 25 patients who had undergone thoracoscopic surgery and compared the outcome to 24 patients who had undergone conventional surgery for spontaneous pneumothorax. The thoracoscopic group was able to return to work and daily activities earlier and had less impairment of shoulder movement. There was a loss of sensation corresponding to the dermatomes where the thoracoscopic ports were placed, which could have resulted from compression of the intercostal nerves by the instruments. However, a similar loss of sensation was found in the thoracotomy group. We conclude that thoracoscopy may be the method of choice for the treatment of spontaneous pneumothorax, although further methodological development should be done.

Entities:  

Mesh:

Year:  1995        PMID: 7773473

Source DB:  PubMed          Journal:  Surg Laparosc Endosc        ISSN: 1051-7200


  3 in total

Review 1.  Preventing recurrence of spontaneous pneumothorax after thoracoscopic surgery: a review of recent results.

Authors:  Takashi Muramatsu; Tatsuhiko Nishii; Shinji Takeshita; Shinichirou Ishimoto; Hiroaki Morooka; Motomi Shiono
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

Review 2.  Surgical access rather than method of pleurodesis (pleurectomy or pleural abrasion) influences recurrence rates for pneumothorax surgery: systematic review and meta-analysis.

Authors:  Andrea Bille; Allanah Barker; Eleni C Maratos; Lyn Edmonds; Eric Lim
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

3.  Bullae ablation in primary spontaneous pneumothorax.

Authors:  Yun-Hen Liu; Yin-Kai Chao; Yi-Chen Wu; Ming-Ju Hsieh; Ching-Yang Wu; Ming-Shian Lu; Chien-Ying Liu; Po-Jen Ko; Hui-Ping Liu
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.